Andrew Newland, chief executive of ANGLE PLC (LON:AGL), discusses with Proactive their significant new collaboration with healthcare giant Abbott Laboratories.
The two will be working on a metastatic breast cancer study.
Abbott will provide its proprietary PathVysion HER-2 DNA FISH Probe kits for ANGLE's ANG-002 US Food & Drug Administration (FDA) study for FISH (fluorescence in situ hybridization) analysis of circulating tumour cells (CTCs) in the form of a research grant.
FISH analysis, which is a form of investigation of the cancer cells used with solid tissue biopsy to help select treatment, is one of the exploratory end-points for ANGLE's FDA study in metastatic breast cancer
Meet Anglo Asian Mining Plc, Condor Gold PLC, Connemara Mining and Papua Mining PLC at our event, London, 08 February 2018.Register here >>